New Drugs 2022-2023

Monday, October 30, 2023

14:00 – 15:00 CT

Location: Hilton Anatole, Cortez AB

CE: 1

ACPE Number: 0202-0000-23-360-L01-P
Activity Type: Knowledge-based

Speaker(s)

Thomas Scott Raisor, PharmD, MPH, MBA, BCACP

Chief Pharmacy and Therapeutics Section
Pharmacy Operations Division Healthcare Operations Directorate Assistant Director Healthcare Administration Pharmacy Operations Division
San Antonio, Texas

Disclosure(s): No financial relationships to disclose

PDF Slides

Disclosure(s):

Thomas Scott Raisor, PharmD, MPH, MBA, BCACP: No financial relationships to disclose

This presentation will review newly FDA-approved, outpatient medications that launched between mid-2022 and mid-2023. It will highlight which medications are novel, which are similar to existing agents, which are orphan drugs, and which pharmacists are most likely to see in their daily jobs. We will take a more in-depth look at approximately 10 novel medications that pharmacists are likely to encounter.

Learning Objectives:

Identify the indications and key characteristics of newly FDA-approved medications launched within the last year
Compare and contrast newly FDA-approved medications with currently available therapeutic options